Locus of control and anti-hypertensive medication adherence in Ghana

Irene Akwo Kretchy, Frances Thelma Owusu-Daaku, Samuel Danquah, Irene Akwo Kretchy, Frances Thelma Owusu-Daaku, Samuel Danquah

Abstract

Introduction: Medication non-adherence is a major public health problem in Ghana. Locus of control (LoC) may influence adherence to medication. In this study we examine the association between locus orientation and adherence to hypertensive medication among adult patients. We also take into account the role of medication side effects.

Methods: We conducted a hospital-based cross-sectional study involving two tertiary hospitals in southern and northern Ghana. Data were collected from 400 hypertensive patients using a structured questionnaire. We gathered information on patient's sociodemographic characteristics, health LoC, side effects of anti-hypertensive medication and adherence to anti-hypertensive medication.

Results: Participants exhibited features of mixed LoC (both internal and external) usually referred to as bi-local expectancy. However, orientation was skewed towards external LoC. Females were marginally more likely than males to have an internal LoC. Education was associated with a greater likelihood of internal LoC. While most patients (93.3%) poorly adhered to antihypertensive medications, logistic regression model revealed that non-adherence was significantly associated with low internal LoC, medication side effects and the combined effect of medication side effects and external LoC.

Conclusion: Medication non-adherence, experiences of medication side effects and LoC are associated. Multifaceted intervention programmes highlighting personality characteristics like LoC may improve anti-hypertensive medication adherence.

Keywords: Ghana; Locus of control; bi-local expectancy; collectivism; culture; hypertension; individualism; medication non-adherence; medication side effects; personality.

References

    1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2224–2260.
    1. Adedoyin RA, Mbada CE, Balogun MO, et al. Prevalence and pattern of hypertension in a semiurban community in Nigeria. Eur J Cardiovasc Prev Rehab. 2008;15:683–687.
    1. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Stichele RV, Van Bortel LM. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011;29(7):1243–1252.
    1. Tesfaye F, Byass P, Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord. 2009;9:39.
    1. World Health Organization. Brazzaville: WHO AFRO; 2008. STEPS Fact Sheet.
    1. Bosu WK. Epidemic of hypertension in Ghana: a systematic review. BMC Public Health. 2010;10:418.
    1. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314.
    1. Nakao M, Yano E, Nomura S, Kuboki T. Blood Pressure-lowering effects of biofeedback treatment in hypertension: a meta-analysis of randomized controlled trials. Hypertens Res. 2003;26(1):37–46.
    1. Willency H. Management of hypertension. Patientplus. 2010:23.
    1. Kabir M, Iliyasu Z, Abubakara IS, Jibrilb M. Compliance to medication among hypertensive patients in Murtala Mohammed Specialist Hospital, Kano, Nigeria. J of CM & Primary Health Care. 2004;16(1):16–20.
    1. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2006;20:67–71.
    1. De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. European J Cardiovasc Nurs. 2003;2:323.
    1. Buabeng KO, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharmaceut Sci. 2004;7(3):350–352.
    1. Okoro RN, Ngong CK. Assessment of patient’s antihypertensive medication adherence level in non-comorbid hypertension in a tertiary hospital in Nigeria. Int J Pharm Biomed Sci. 2012;3(2):47–54.
    1. Ho MP, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–3035.
    1. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med. 2005;353:487–497.
    1. Singh A. Personality characteristics, locus of control and hostility among alcoholics and non-alcoholics. IJPS. 2011;3(1):99–105.
    1. Lynam I, Catley D, Goggin K, Rabinowitz JL, et al. Autonomous regulation and locus of control as predictors of antiretroviral medication adherence. J Health Psychol. 2009;14:578.
    1. Burkhart PV, Rayens MK. Self-concept and health locus of control: factors related to children’s adherence to recommended asthma regimen. Pediatr Nurs. 2005;31(5):404–9.
    1. Omeje O, Nebo C. The Influence of locus of control on adherence to treatment regimen among hypertensive patients. Patient Prefer Adherence. 2011;5:141–148.
    1. Halimi L, Pry R, Pithon G, Godard P, Varrin M, Chanez P. Severe asthma and adherence to peak flow monitoring: longitudinal assessment of psychological aspects. J Psychosom Res. 2010;69(4):331–40.
    1. Combes C, Feral F. Drug compliance and health locus of control in schizophrenia. Encephale. 2011;37(1):S11–18.
    1. Bellini A, Zanchi C, Martelossi S, Di Leo G, Not T, Ventura A. Compliance with the gluten-free diet: the role of locus of control in celiac disease. J Pediatr. 2011;158(3):463–466.
    1. Morowatisharifabad MA, Mahmoodabad SS, Baghianimoghadam MH, Tonekaboni NR. Relationships between locus of control and adherence to diabetes regimen in a sample of Iranians. Int J Diabetes Dev Ctries. 2010;30(1):27–32.
    1. Wallston KA, Wallston BS. Who is responsible for your health: the construct of health locus of control. In: Sanders G, Suls J, editors. Social Psychology of Health and Illness. Hillsdale, N.J.: Lawrence Erlbaum & Associates; 1982. pp. 65–95.
    1. Cebi M. Locus of control and human capital investment revisited. J Hum Resour. 2007;17:919–932.
    1. Schurer S. Discrete heterogeneity in the effects of health shocks on labour market outcomes; 2008. Melbourne Institute Working Paper 19/08.
    1. Heineck G, Anger S. The returns to cognitive abilities and personality traits in Germany. Labour Economics. 2010;17:535–546.
    1. Malcarne VL, Drahota A, Hamilton NA. Children’s health- related locus of control beliefs: ethnicity, gender, and family income. Child Health Care. 2005;34:47–59.
    1. Theimann NM, April K, Blass E. Context tension: Cultural influences on leadership and management practice. SoL Reflections. 2006;7:38–51.
    1. Azlin B, Hatta S, Norzila Z, Sharifa Ezat WP. Health locus of control among non-compliance hypertensive patients undergoing pharmacotherapy. MJP. 2007;16(1):20–39.
    1. Spector PE, Cooper CL, Sanchez JI, et al. Locus of control and well-being at work: How generalizable are Western findings? Acad Manage J. 2002;45:453–466.
    1. Stocks A, April KA, Lynton N. Locus of control and subjective well-being – a cross-cultural study. Probl Perspect Manag. 2012;10(1):17.
    1. Jackson T. International HRM: A cross-cultural approach. London: Sage; 2002.
    1. Gyapong J, Garshong B, Akazili J, Aikins M. Critical analysis of Ghana’s health system with a focus on equity challenges and the national health insurance; 2007. SHIELD Workpackage 1 Report.
    1. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. AOS. 2006;1:9–14.
    1. Gravetter FJ, Forzano LB. Research Methods for Behavioural Sciences. 4th Ed. Australia: Thomson Wadsworth; 2009. pp. 519–521.
    1. Krousel-Wood MA, Islam T, Webber LS, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag C. 2009;15(1):59–66.
    1. Wallston KA, Wallston BS, DeVellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr. 1978;6(2):160–170.
    1. Wallston KA, Stein MJ, Smith CA. Form C of the MHLC Scales: A Condition-specific measure of locus of control. J Pers Assess. 1994;63:534–553.
    1. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.
    1. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18:607–613.
    1. April K, Dharani B, Peters BKG. Impact of locus of control expectancy on level of well-being. RES. 2012;4(2):124–137.
    1. Masthoff J. Design and evaluation of a navigation agent with a mixed locus of control. In: Cerri SA, Gouarderes G, Paraguacu F, editors. Intelligent Tutoring Systems: Proceedings ITS 2002: 6th International Conference; 2002. Jun 2-7, ITS 2002.
    1. Holland C, Geraghty J, Shah K. Differential moderating effect of locus of control on effect of driving experience in young male and female drivers. Pers Indiv Differ. 2010;48:821–826.
    1. Jain S, Singh AP. Locus of control in relation to cognitive complexity. IAAP. 2008;34(1):107–113.
    1. Hamedoglu MA, Kantor J, Gülay E. The effect of locus of control and culture on leader preferences. IOJES. 2012;4(2):319–324.
    1. Sariçam H, Duran A, Çardak M, Halmatov M. The examination of pre-school teacher candidates’ academic locus of control levels according to gender and grade. MIJE. 2012;2(2):67–74.
    1. Hong TB, Oddone EZ, Dudley TK, Bosworth HB. Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control. Psychol Health Med. 2006;11(1):20–8.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj